IRIS
AGUSTONI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 223
EU - Europa 156
AS - Asia 60
Totale 439
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 223
IT - Italia 73
CN - Cina 53
IE - Irlanda 36
FI - Finlandia 29
DE - Germania 8
JP - Giappone 6
FR - Francia 3
NL - Olanda 3
BE - Belgio 2
CZ - Repubblica Ceca 1
PL - Polonia 1
SG - Singapore 1
Totale 439
Salva come PNG Salva come JPEG
Città #
Ashburn 61
Dublin 36
Shanghai 35
Helsinki 29
New York 22
Boardman 20
Pavia 14
Milan 9
Rome 8
Seattle 8
Beijing 7
Cesena 7
Palermo 6
Tokyo 6
Bondo 4
Washington 4
Maastricht 3
Casatenovo 2
Castel del Giudice 2
Chandler 2
Drexel Hill 2
Rocca Canavese 2
Villanuova sul Clisi 2
Wilrijk 2
Arezzo 1
Falkenstein 1
Forest City 1
Guangzhou 1
Hangzhou 1
Misterbianco 1
Munich 1
Myszkow 1
Olomouc 1
Ponteranica 1
Singapore 1
Tianjin 1
Wuhan 1
Xining 1
Totale 307
Salva come PNG Salva come JPEG
Nome #
Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience 28
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 26
Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer 22
Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results 21
Preliminary report on harmonization of features extraction process using the ComBat tool in the multi-center "Blue Sky Radiomics" study on stage III unresectable NSCLC 20
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 19
Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study 18
EGFR-directed monoclonal antibodies in combination with chemotherapy for treatment of non-small-cell lung cancer: an updated review of clinical trials and new perspectives in biomarkers analysis 17
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 17
Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach 17
Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling 17
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 16
Pragmatic Expectancy on Microbiota and Non-Small Cell Lung Cancer: A Narrative Review 15
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC) 15
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study 15
CT Scan-Guided Fine Needle Aspiration Cytology for Lung Cancer Diagnosis through the COVID-19 Pandemic: What We Have Learned 13
Nutritional support in lung cancer: Time to combine immunonutrition with immunotherapy? 13
Smoking Habit and Respiratory Function Predict Patients' Outcome after Surgery for Lung Cancer, Irrespective of Histotype and Disease Stage 13
Impact of hyponatremia in a tertiary cancer center: a one-year-survey at National Cancer Institute of Milan 13
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era 12
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study 12
Radiomics features as predictive and prognostic biomarkers in NSCLC 12
From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers-A Multidisciplinary Perspective 10
The Clinical Value of Nutritional Care before and during Active Cancer Treatment 10
Epidermal growth factor receptor tyrosine kinase inhibitor treatment in patients with EGFR wild-type non-small-cell lung cancer: the never-ending story 8
Gemcitabine-induced thrombocytosis as a potential predictive factor in non-small cell lung cancer: analysis of 318 patients 8
A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell Lines 8
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin 8
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib 8
EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC 7
Indoleamine 2,3-Dioxygenase Expression in Non-Small-Cell Lung Cancer: Analyses of Prevalence, Clinical Correlations and Prognostic Impact 7
The Evolving Landscape of the Molecular Epidemiology of Malignant Pleural Mesothelioma 7
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry 7
The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs 6
PACIFIC trial: new perspectives for immunotherapy in lung cancer 4
Rationale and Design of a Single-Arm, Phase 2, Multi-Center Study of Chemo-Immunotherapy Followed by Hypo-Fractionated RT and Maintenance Immunotherapy in Patients With Unresectable Stage III NSCLC: The DEDALUS Trial 4
Small-Cell Lung Cancer: Clinical Management and Unmet Needs New Perspectives for an Old Problem 4
Palonosetron: an evidence-based choice in prevention of nausea and vomiting induced by moderately emetogenic chemotherapy 2
Palonosetron in the prevention of chemotherapy-induced nausea and vomiting: an evidence-based review of safety, efficacy, and place in therapy 2
Totale 481
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.393
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023137 0 0 0 0 8 0 1 3 31 0 79 15
2023/2024343 40 46 29 27 31 69 31 15 0 18 6 31
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 481